Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson and Johnson, shared a post on X:
“So excited to be here at the SU2C Science meeting and SU2C Scientific Summit. Collaboration and partnership are the keys to cancer research and the discussions here are vibrant.”
More posts featuring Mark Wildgust.